Try our Advanced Search for more refined results

AstraZeneca Opposes MDL In Nexium Bone Density Suits

By Jess Krochtengel (November 29, 2012, 7:13 PM EST) -- AstraZeneca LP on Thursday asked the U.S. Judicial Panel on Multidistrict Litigation not to consolidate nearly 40 individual cases and putative class actions that allege taking the heartburn drug Nexium causes bone density loss, saying causation issues in the cases are too disparate....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!